|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 45/06 |
| (11) | Number of the document | 1962903 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06820476.7 |
| Date of filing the European patent application | 2006-12-12 | |
| (97) | Date of publication of the European application | 2008-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2006/004611 |
| Date | 2006-12-12 |
| (87) | Number | WO 2007/068895 |
| Date | 2007-06-21 |
| (30) | Number | Date | Country code |
| 750551 P | 2005-12-15 | US |
| (72) |
BROWN, Jeffrey, Lester, US
EMERY, Stephen, Charles, GB
BLAKEY, David, Charles, GB
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
|
| (54) | COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER |
| COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER |